Veracyte | VCYT - Assets


Veracyte reported $1.41B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Agenus USD 226.8M 7.09M Dec/2025
Agilent USD 12.81B 86M Dec/2025
Anika Therapeutics USD 190.27M 833K Dec/2025
Arrowhead Research USD 1.6B 218.89M Dec/2025
Bruker USD 6.24B 193.5M Dec/2025
Heron Therapeutics USD 255.88M 6.93M Dec/2025
Illumina USD 6.64B 467M Dec/2025
Intrexon USD 73.16M 77.88M Jun/2024
Karyopharm Therapeutics USD 108.42M 12.18M Dec/2025
Laboratory Of America USD 18.39B 131.1M Dec/2025
Ligand Pharmaceuticals USD 1.56B 83.86M Dec/2025
Myriad Genetics USD 706.6M 21.5M Dec/2025
Rigel Pharmaceuticals USD 242.53M 35.8M Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
Siemens EUR 170.13B 3.93B Dec/2025
Sonic Healthcare AUD 15.38B 550.57M Dec/2024
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Veracyte USD 1.41B 38.23M Dec/2025
Waters USD 5.08B 221.41M Dec/2025